- Corporate Officers - Y
- Yerxa Benjamin R
Insider Trading History of Yerxa Benjamin R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yerxa Benjamin R since 2008.
This trader's CIK number is 1145910.
At the time of last reporting, Yerxa Benjamin R was the President of Opus Genetics, Inc.. (stock ticker symbol IRD).
Also see all insider trading activities at Opus Genetics, Inc..
Note that in the past
YERXA BENJAMIN R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Clearside Biomedical, Inc. (CLSD) by Yerxa Benjamin R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CLSD | 7,813 | $10,235 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inspire Pharmaceuticals Inc (ISPH) by Yerxa Benjamin R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ISPH | 0 | $0 | 10,000 | $60,432 | 0 | $0 |
| 2009 | ISPH | 0 | $0 | 18,125 | $93,942 | 0 | $0 |
| 2008 | ISPH | 0 | $0 | 0 | $0 | 32,257 | $11,119 |
Yearly summary of insider trading at Opus Genetics, Inc. (IRD) by Yerxa Benjamin R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | IRD | 10,000 | $9,830 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Yerxa Benjamin R:
1. Clearside Biomedical, Inc. (CLSD)
2. Inspire Pharmaceuticals Inc (ISPH)
3. Opus Genetics, Inc. (IRD)
Table 1. Insider trading of Clearside Biomedical, Inc. (CLSD) by Yerxa Benjamin R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-15 | CLSD | Buy | 7,813 | 1.31 | 10,235 |
Table 2. Insider trading of Inspire Pharmaceuticals Inc (ISPH) by Yerxa Benjamin R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-05-03 | ISPH | Sale | 2,000 | 6.76 | 13,524 |
| 2010-04-01 | ISPH | Sale | 2,000 | 6.30 | 12,604 |
| 2010-03-01 | ISPH | Sale | 2,000 | 6.13 | 12,264 |
| 2010-02-01 | ISPH | Sale | 2,000 | 5.43 | 10,856 |
| 2010-01-04 | ISPH | Sale | 2,000 | 5.59 | 11,184 |
| 2009-12-01 | ISPH | Sale | 2,000 | 5.70 | 11,394 |
| 2009-11-02 | ISPH | Sale | 2,000 | 4.56 | 9,114 |
| 2009-10-01 | ISPH | Sale | 2,000 | 5.19 | 10,384 |
| 2009-09-01 | ISPH | Sale | 2,000 | 5.69 | 11,372 |
| 2009-08-03 | ISPH | Sale | 2,000 | 4.83 | 9,660 |
| 2009-07-01 | ISPH | Sale | 2,000 | 5.61 | 11,210 |
| 2009-06-15 | ISPH | Sale | 6,125 | 5.03 | 30,808 |
| 2008-11-04 | ISPH | Option Ex | 9,131 | .42 | 3,835 |
| 2008-05-13 | ISPH | Option Ex | 23,126 | .32 | 7,284 |
Table 3. Insider trading of Opus Genetics, Inc. (IRD) by Yerxa Benjamin R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-11-21 | IRD | Buy | 10,000 | .98 | 9,830 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Yerxa Benjamin R
(President of Opus Genetics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.